CN116211949A - Aloe pearl capsule and preparation method thereof - Google Patents

Aloe pearl capsule and preparation method thereof Download PDF

Info

Publication number
CN116211949A
CN116211949A CN202210515270.0A CN202210515270A CN116211949A CN 116211949 A CN116211949 A CN 116211949A CN 202210515270 A CN202210515270 A CN 202210515270A CN 116211949 A CN116211949 A CN 116211949A
Authority
CN
China
Prior art keywords
aloe
pearl
parts
preparation
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210515270.0A
Other languages
Chinese (zh)
Inventor
冯胜军
冯朝
尉杰
李伟
鲁延清
郭峰
王红杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Junlin Pharmaceutical Co ltd
Original Assignee
Hebei Junlin Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Junlin Pharmaceutical Co ltd filed Critical Hebei Junlin Pharmaceutical Co ltd
Priority to CN202210515270.0A priority Critical patent/CN116211949A/en
Publication of CN116211949A publication Critical patent/CN116211949A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The invention provides an aloe pearl capsule and a preparation method thereof, wherein the aloe pearl capsule comprises the following components: 100 parts of aloe, 450-550 parts of costustoot and 45-55 parts of pearl; the aloe pearl capsules provided by the invention are prepared in a reasonable relationship and have a specific proportion, and are beneficial to the effects of clearing the intestines and defecating, improving the intestinal tracts and promoting the peristalsis of the intestines and the stomach. The aloe, the costustoot and the pearl are mixed according to the ratio of 2:10:1, so that the health care effect can be achieved when the patient has the effects of promoting digestion, resolving food stagnation, resolving phlegm and heat, clearing heat and detoxicating, and treating constipation.

Description

Aloe pearl capsule and preparation method thereof
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to an aloe pearl capsule and a preparation method thereof
Background
Constipation refers to the reduction of defecation times, difficulty in defecation and dry feces; the defecation times per week are less than 3 times, and the disease course is more than 6 months. The prevalence rate of chronic constipation for adults in China is 4-6%, and the prevalence rate of chronic constipation for people over 60 years old is 22%. The causes of chronic constipation are numerous, including: reduced daily activity, increased mental stress, insufficient fiber or fluid intake due to unbalanced diet, reduced intestinal peristalsis due to reduced body function, atrophy of intestinal mucosa and intestinal wall fibers, etc. The prevalence rate of constipation of the elderly is obviously increased in younger and older people, mainly because with the increase of age, the food intake and physical activity of the elderly are obviously reduced, gastrointestinal secretion digestive juice is reduced, tension and peristalsis of intestinal tracts are weakened, abdominal cavity and pelvic floor muscles are weakened, internal and external sphincter anus is weakened, gastric colon reflection is weakened, rectal sensitivity is reduced, food stays in the intestines for too long, and excessive moisture absorption causes constipation.
In terms of treatment, at present, most Western medicine adopts permeability, irritation and lubricating laxatives (such as lactulose, enema, polyethylene glycol and the like) and secretagogues and prokinetic medicines, but the adverse effects of medicine treatment are more, and long-term administration is easy to generate dependence and influence the absorption of calcium, phosphorus and fat-soluble vitamins, and the long-term administration of the irritation laxative can cause irreversible enteric nerve damage.
Disclosure of Invention
The invention aims to overcome the defects and provide the traditional Chinese medicine composition aloe pearl capsules with good curative effect and small side effect and the preparation method thereof.
In a first aspect of the invention, there is provided an aloe pearl capsule comprising the following components by weight:
component (A) Parts by weight
Aloe vera 100 parts of
Radix aucklandiae 450-550 parts
Pearl 45-55 parts
Preferably, the composition comprises the following components in weight:
component (A) Parts by weight
Aloe vera 100 parts of
Radix aucklandiae 490-505
Pearl 49-51 parts
More preferably, the composition comprises the following components in weight:
component (A) Parts by weight
Aloe vera 100 parts of
Radix aucklandiae 500 parts of
Pearl 50 parts of
Furthermore, the aloe pearl capsule also comprises pharmaceutically acceptable auxiliary materials, wherein the auxiliary materials are preferably corn starch, lecithin and beta-cyclodextrin; the beta-cyclodextrin is preferably sulfobutyl beta-cyclodextrin.
Further, the weight of the sulfobutylcyclodextrin is 0.2-0.3 times, preferably 0.26-0.28 times of the weight of the costustoot.
The second aspect of the invention provides a preparation method of the aloe pearl capsule.
A preparation method of aloe pearl capsule comprises the following steps:
(1) Pretreatment:
preparation of the costustoot extract: crushing radix aucklandiae, soaking in 7-10 times of water for 3-5 hr, adding lecithin, extracting volatile oil by steam distillation for 1-2 hr, adding sodium bicarbonate to adjust pH to 8.0-8.5, adding alkaline protease, steam distilling for 1-2 hr, adding flavourzyme, steam distilling for 1-2 hr, collecting volatile oil, clathrating with sulfobutyl betacyclodextrin, and collecting clathrate. Filtering the extracting solution, and concentrating to obtain fluid extract (called costustoot fluid extract for short) with the relative density of 1.2-1.3.
Preparation of aloe extract: pulverizing aloe, reflux extracting with 3 times of 75-85% ethanol for 0.2-1.0 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.15-1.20 (aloe fluid extract for short).
Preparing pearl powder: pulverizing Margarita to obtain Margarita powder with D90 of not more than 28 μm.
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring.
(3) Preparation of aloe pearl capsules: and (3) subpackaging the content of the capsule prepared in the step (2) to obtain the aloe pearl capsule.
Wherein, the liquid crystal display device comprises a liquid crystal display device,
the weight of lecithin is 0.01-0.1 times, preferably 0.06 times of the weight of radix aucklandiae.
The alkaline protease is 0.02-0.06 times, preferably 0.04 times of the weight of radix aucklandiae.
The weight of the flavourzyme is 0.08-0.15 times of the weight of the costustoot, preferably 0.12 times.
Compared with the prior art, the invention has the following beneficial effects:
(1) The raw materials are safer; the aloe, the costustoot, the pearl and the like are used as components for treating constipation, so that the raw materials are safe to use; animal tests and crowd trial prove that the aloe pearl capsules can treat constipation, promote defecation of patients and have no toxic or side effect.
(2) The aloe pearl capsules provided by the invention are prepared in a reasonable relationship and have a specific proportion, and are beneficial to the effects of clearing the intestines and defecating, improving the intestinal tracts and promoting the peristalsis of the intestines and the stomach. The aloe, the costustoot and the pearl are mixed according to the ratio of 2:10:1, so that the health care effect can be achieved when the patient has the effects of promoting digestion, resolving food stagnation, resolving phlegm and heat, clearing heat and detoxicating, and treating constipation.
(3) According to the preparation method provided by the invention, the components in the raw materials are processed respectively, so that mutual interference among the raw materials is avoided, the drug effect of the raw materials is brought into play, particularly the elecampane is extracted by adopting a specific method, the obtained volatile oil and the extracting solution are utilized, the effects of the volatile oil and the extracting solution are fully brought into play, and unexpected technical effects are achieved.
Detailed Description
The invention discloses an aloe pearl capsule and a preparation method thereof, and the aloe pearl capsule can be realized by combining the related principles of medicine extraction and medicine preparation by combining the content of the invention with proper improvement of technological parameters by a person skilled in the art. It is expressly noted that all such similar substitutions and modifications will be apparent to those skilled in the art, and are deemed to be included within the scope of the present invention. While the invention has been described with reference to preferred embodiments, it will be apparent to those skilled in the relevant art that variations and modifications can be made in the methods and applications described herein, or in appropriate changes and combinations, without departing from the spirit and scope of the invention.
For a better understanding of the present invention, and not to limit its scope, all numbers expressing quantities, percentages, and other values used in the present application are to be understood as being modified in all instances by the term "about". Each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
The invention is further illustrated by the following examples, which are not intended to limit the invention in any way.
Example 1: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 100 parts of 100
Radix aucklandiae 500 parts of 500
Pearl 50 parts of 50
Sulfobutyl betacyclodextrin 130 parts of 130
Corn starch 200 parts of 200
The preparation method comprises the following steps:
(1) Pretreatment:
preparation of the costustoot extract: the method comprises the steps of crushing the radix aucklandiae, adding 8 times of water, soaking for 4 hours, adding 30g (30 parts) of lecithin, extracting volatile oil by a steam distillation method for 1.5 hours, adding sodium bicarbonate to adjust the pH to 8.3, adding 20g (20 parts) of alkaline protease, continuing steam distillation for 1.5 hours, adding 60g (60 parts) of flavourzyme, continuing steam distillation for 1.5 hours, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.25 (radix aucklandiae fluid extract for short).
Preparation of aloe extract: pulverizing Aloe, reflux-extracting with 3 times of 80% ethanol for 0.5 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.18 (aloe fluid extract for short).
Preparing pearl powder: the pearl powder with D90 of 15 μm is obtained by pulverizing the pearl.
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring.
(3) Preparation of aloe pearl capsules: and (3) subpackaging the capsule content prepared in the step (2) to obtain aloe pearl capsules (1000 capsules).
Example 2: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 100 parts of 100
Radix aucklandiae 500 parts of 500
Pearl 50 parts of 50
Sulfobutyl betacyclodextrin 140 parts 140
Corn starch 200 parts of 200
The preparation method comprises the following steps:
(1) Pretreatment:
preparation of the costustoot extract: crushing radix aucklandiae, adding 9 times of water, soaking for 4 hours, adding 30g (30 parts) of lecithin, extracting volatile oil by a steam distillation method for 1.5 hours, adding sodium bicarbonate to adjust the pH to 8.2, adding 20g (20 parts) of alkaline protease, continuing steam distillation for 1-2 hours, adding 60g (60 parts) of flavourzyme, continuing steam distillation for 1.5 hours, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.27 (radix aucklandiae fluid extract for short).
Preparation of aloe extract: pulverizing Aloe, reflux-extracting with 3 times of 80% ethanol for 0.6 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.17 (aloe fluid extract for short).
Preparing pearl powder: pulverizing Margarita to obtain Margarita powder with D90 of 18 μm.
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring.
(3) Preparation of aloe pearl capsules: and (3) subpackaging the capsule content prepared in the step (2) to obtain aloe pearl capsules (1000 capsules).
Example 3: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 100 parts of 100
Radix aucklandiae 490 parts of 490
Pearl 49 parts of 49
Sulfobutyl betacyclodextrin 120 parts of 120
Corn starch 200 parts of 200
The preparation method comprises the following steps:
(1) Pretreatment:
preparation of the costustoot extract: the method comprises the steps of crushing the radix aucklandiae, adding 8 times of water, soaking for 4 hours, adding 25g (25 parts) of lecithin, extracting volatile oil by a steam distillation method for 1.5 hours, adding sodium bicarbonate to adjust the pH to 8.1, adding 25g (25 parts) of alkaline protease, continuing steam distillation for 1.5 hours, adding 65g (65 parts) of flavourzyme, continuing steam distillation for 1.5 hours, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.22 (radix aucklandiae fluid extract for short).
Preparation of aloe extract: pulverizing Aloe, reflux-extracting with 3 times of 80% ethanol for 0.4 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.18 (aloe fluid extract for short).
Preparing pearl powder: the pearl powder with D90 of 20.5 μm is obtained by pulverizing the pearl.
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring.
(3) Preparation of aloe pearl capsules: and (3) subpackaging the capsule content prepared in the step (2) to obtain aloe pearl capsules (1000 capsules).
Example 4: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 100 parts of 100
Radix aucklandiae 505 parts 505
Pearl 51 parts of 51
Sulfobutyl betacyclodextrin 110 parts of 110
Corn starch 200 parts of 200
(1) Pretreatment:
preparation of the costustoot extract: the method comprises the steps of crushing the costustoot, adding 9 times of water, soaking for 4 hours, adding 35g (35 parts) of lecithin, extracting volatile oil by a steam distillation method for 1.5 hours, adding sodium bicarbonate to adjust the pH to 8.4, adding 15g (15 parts) of alkaline protease, continuing steam distillation for 1.5 hours, adding 55g (55 parts) of flavourzyme, continuing steam distillation for 1.5 hours, collecting the volatile oil, clathrating the volatile oil by sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.28 (radix aucklandiae fluid extract for short).
Preparation of aloe extract: pulverizing Aloe, reflux-extracting with 3 times of 80% ethanol for 0.7 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.19 (aloe fluid extract for short).
Preparing pearl powder: the pearl powder with D90 of 21 μm is obtained by pulverizing the pearl.
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring.
(3) Preparation of aloe pearl capsules: and (3) subpackaging the capsule content prepared in the step (2) to obtain aloe pearl capsules (1000 capsules).
Example 5: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 100 parts of 100
Radix aucklandiae 450 parts of 450
Pearl 55 parts of 55
Sulfobutyl betacyclodextrin 100 parts of 100
Corn starch 200 parts of 200
(1) Pretreatment:
preparation of the costustoot extract: the method comprises the steps of crushing the costustoot, adding 7 times of water, soaking for 5 hours, adding 45g (45 parts) of lecithin, extracting volatile oil by a steam distillation method for 1 hour, adding sodium bicarbonate to adjust the pH to be 8, adding 11g (11 parts) of alkaline protease, continuing steam distillation for 1 hour, adding 67g (67 parts) of flavourzyme, continuing steam distillation for 1 hour, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.21 (radix aucklandiae fluid extract for short).
Preparation of aloe extract: pulverizing Aloe, reflux-extracting with 3 times of 75% ethanol for 0.3 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.2 (aloe fluid extract for short).
Preparing pearl powder: the pearl powder with D90 of 26 μm is obtained by pulverizing the pearl.
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring.
(3) Preparation of aloe pearl capsules: and (3) subpackaging the capsule content prepared in the step (2) to obtain aloe pearl capsules (1000 capsules).
Example 6: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 100 parts of 100
Radix aucklandiae 550 parts 550
Pearl 45 parts of 45
Sulfobutyl betacyclodextrin 100 parts of 100
Corn starch 200 parts of 200
The preparation method comprises the following steps:
(1) Pretreatment:
preparation of the costustoot extract: the method comprises the steps of crushing the radix aucklandiae, adding 10 times of water, soaking for 3 hours, adding 22g (22 parts) of lecithin, extracting volatile oil by a steam distillation method for 2 hours, adding sodium bicarbonate to adjust the pH to 8.5, adding 27g (27 parts) of alkaline protease, continuing steam distillation for 2 hours, adding 44g (44 parts) of flavourzyme, continuing steam distillation for 2 hours, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.26 (radix aucklandiae fluid extract for short).
Preparation of aloe extract: pulverizing Aloe, reflux-extracting with 3 times of 85% ethanol for 1 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.15 (aloe fluid extract for short).
Preparing pearl powder: the pearl powder with D90 of 27.1 μm is obtained by pulverizing the pearl.
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring.
(3) Preparation of aloe pearl capsules: and (3) subpackaging the capsule content prepared in the step (2) to obtain aloe pearl capsules (1000 capsules).
Comparative example 1: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 300 parts of 300
Radix aucklandiae 300 parts of 300
Pearl 50 parts of 50
Sulfobutyl betacyclodextrin 130 parts of 130
Corn starch 200 parts of 200
The preparation method comprises the following steps: as in example 1.
Comparative example 2: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 500 parts of 500
Radix aucklandiae 100 parts of 100
Pearl 50 parts of 50
Sulfobutyl betacyclodextrin 130 parts of 130
Corn starch 200 parts of 200
The preparation method comprises the following steps: as in example 1.
Comparative example 3: aloe pearl capsule
Component (A) Parts by weight Weight (g)
Aloe vera 100 parts of 100
Radix aucklandiae 500 parts of 500
Pearl 50 parts of 50
Sulfobutyl betacyclodextrin 50 parts of 50
Corn starch 200 parts of 200
The preparation method comprises the following steps: same as in example 1
Comparative example 4: aloe pearl capsule
The components are as follows: as in example 1.
Comparative example 4-1: the preparation method comprises the following steps: the preparation of the costustoot extract in the step (1) is as follows, with the remainder being as in example 1.
(1) Pretreatment:
preparation of the costustoot extract: the method comprises the steps of crushing the radix aucklandiae, adding 8 times of water, soaking for 4 hours, adding 188 g (30 parts) of poloxamer, extracting volatile oil by a steam distillation method for 1.5 hours, adding sodium bicarbonate to adjust the pH to be 8.3, adding 20g (20 parts) of alkaline protease, continuing steam distillation for 1.5 hours, adding 60g (60 parts) of flavourzyme, continuing steam distillation for 1.5 hours, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.25 (radix aucklandiae fluid extract for short).
Comparative example 4-2: the preparation method comprises the following steps: the preparation of the costustoot extract in the step (1) is as follows, with the remainder being as in example 1.
(1) Pretreatment:
preparation of the costustoot extract: the method comprises the steps of crushing the radix aucklandiae, adding 8 times of water, soaking for 4 hours, extracting volatile oil by a steam distillation method for 1.5 hours, adding sodium bicarbonate to adjust the pH to be 8.3, adding 20g (20 parts) of alkaline protease, continuing steam distillation for 1.5 hours, adding 60g (60 parts) of flavourzyme, continuing steam distillation for 1.5 hours, collecting the volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.25 (radix aucklandiae fluid extract for short).
Comparative example 5: aloe pearl capsule
The components are as follows: as in example 1.
Comparative example 5-1: the preparation method comprises the following steps: the preparation of the costustoot extract in the step (1) is as follows, with the remainder being as in example 1.
Preparation of the costustoot extract: the method comprises the steps of crushing the radix aucklandiae, adding 8 times of water, soaking for 4 hours, adding 30g (30 parts) of lecithin, extracting volatile oil by a steam distillation method for 3.0 hours, adding 60g (60 parts) of flavourzyme, continuously steam distilling for 1.5 hours, collecting the volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and keeping the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.25 (radix aucklandiae fluid extract for short).
Comparative example 5-2: the preparation method comprises the following steps: the preparation of the costustoot extract in the step (1) is as follows, with the remainder being as in example 1.
Preparation of the costustoot extract: the method comprises the steps of crushing the radix aucklandiae, adding 8 times of water, soaking for 4 hours, adding 30g (30 parts) of lecithin, extracting volatile oil by a steam distillation method for 1.5 hours, adding sodium bicarbonate to adjust the pH to 8.3, adding 20g (20 parts) of alkaline protease, continuing steam distillation for 3.0 hours, adding 60g (60 parts) of flavourzyme, continuing steam distillation for 1.5 hours, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and standing the clathrate for later use. Filtering the extractive solution, and concentrating to obtain fluid extract with relative density of 1.25 (radix aucklandiae fluid extract for short).
Example 7: effect evaluation:
1. test design
Male C57BL/6 mice, weighing 20-30g, 10 in each group, 150 in total. Divided into 15 groups
Wherein 140 mice are filled with the stomach molding drug loperamide hydrochloride with the dosage of 50mg/Kg, and the stomach is continuously filled for 7 days, so as to establish a mouse intestinal constipation model. Another 10 blank groups;
test article: 13 groups of aloe pearl capsules prepared in examples 1-6 and comparative examples 1-5 are prepared, and the model control group does not take any medicine; the doses were 2.5g (aloe pearl capsule content)/kg (mice), respectively, and the administration was performed once daily for 5 days.
Observing the first defecation time (min) and the weight (g) of the excrement
2. Test results
Group of First defecation time (min) Fecal weight (g)
Blank control group 208.4±31.59## 0.87±0.17##
Model control group 295.8±44.87** 0.50±0.24**
Example 1 212.8±32.39## 0.83±0.23##
Example 2 217.7±33.32## 0.72±0.23##
Example 3 206.4±30.31## 0.71±0.21##
Example 4 221.2±33.11## 0.62±0.25##
Example 5 243.7±36.83#★ 0.61±0.17#
Example 6 244.5±37.53#★ 0.44±0.07#
Comparative example 1 210.4±32.15## 0.49±0.13★★
Comparative example 2 230.0±34.04## 0.50±0.07★★
Comparative example 3 268.0±41.02★★ 0.51±0.07★★
Comparative example 4-1 280.7±42.64★★ 0.54±0.16★★
Comparative example 4-2 270.3±40.11★★ 0.55±0.15★★
Comparative example 5-1 279.0±41.49★★ 0.52±0.09★★
Comparative example 5-2 274.3±40.72★★ 0.52±0.22★★
Note that: #p <0.05; # P <0.01; compared with the model group
* P <0.05; * P <0.01; compared with the blank control group
P <0.05; p <0.01; compared with the group of the embodiment 1
(1) Compared with the blank control group, the first defecation time of the model group is obviously increased, the weight of excrement is obviously reduced, and the two have very obvious difference (P is less than 0.01), which indicates that the model is successful.
(2) Compared with a model control group, the aloe pearl capsules prepared in examples 1-6 can remarkably reduce the first defecation time and improve the weight of excrement, and have remarkable differences (P is less than 0.01 or P is less than 0.05), which indicates that the aloe pearl capsules prepared in examples 1-6 treat constipation.
(3) Compared with a model control group, the aloe pearl capsules prepared in the comparative examples 1-2 can remarkably reduce the first defecation time, and the difference is very remarkable (P is less than 0.01), and the weight of excrement is improved but not remarkable (P is more than 0.05), so that the aloe pearl capsules prepared in the comparative examples 1-2 cannot be used for treating constipation.
(4) Compared with the model control group, the aloe pearl capsules prepared in the comparative examples 3-5 can reduce the first defecation time and improve the fecal weight, but have no significant difference (P > 0.05), which indicates that the aloe pearl capsules prepared in the comparative examples 3-5 can not be used for treating constipation.
(4) Compared with the group of the example 1, the aloe pearl capsules prepared in the comparative examples 1-2 can reduce the first defecation time without significant difference (P is more than 0.05), which shows that the aloe pearl capsules are convenient to reduce the first defecation time and are similar to the group of the example 1; however, the aloe pearl capsules prepared in comparative examples 1-2 have very significant differences in increasing the weight of feces (P < 0.01), which indicates that the aloe pearl capsules prepared in comparative examples 1-2 have significantly poorer constipation treating effect than the aloe pearl capsules prepared in example 1, and have very significant differences (P < 0.01).
(4) Compared with the group of the example 1, the aloe pearl capsules prepared in the comparative examples 3-5 can reduce the first defecation time and improve the fecal weight, but all have very significant differences (P < 0.01), which indicates that the aloe pearl capsules prepared in the comparative examples 3-5 have significantly worse constipation treating effect than the group of the example 1 and very significant differences (P < 0.01)
Therefore, only the aloe, the costustoot and the pearl are extracted according to a specific proportion in a proportion mode of 2:10:1 by adopting a specific method, particularly the costustoot, the volatile oil and the extracting solution are both utilized, and the prepared aloe pearl capsule can effectively treat constipation.

Claims (9)

1. An aloe pearl capsule comprises the following components in parts by weight:
Figure FDA0003639262310000011
2. the aloe pearl capsule according to claim 1, which comprises the following components
Figure FDA0003639262310000012
3. The aloe pearl capsule according to claim 2, which comprises the following components:
Figure FDA0003639262310000013
4. the aloe pearl capsule according to claim 3, further comprising pharmaceutically acceptable excipients, preferably corn starch, lecithin, betacyclodextrin; the beta-cyclodextrin is preferably sulfobutyl beta-cyclodextrin.
5. The aloe pearl capsule according to claim 4, wherein said sulfobutylcyclodextrin is 0.2 to 0.3 times, preferably 0.26 to 0.28 times the weight of banksia rose.
6. A method of preparing the aloe pearl capsule according to claim 5, comprising the steps of:
(1) Pretreatment:
preparation of the costustoot extract: crushing radix aucklandiae, adding 7-10 times of water, soaking for 3-5 hours, adding lecithin, extracting volatile oil by a steam distillation method for 1-2 hours, adding sodium bicarbonate to adjust the pH to 8.0-8.5, adding alkaline protease, continuing steam distillation for 1-2 hours, adding flavourzyme, continuing steam distillation for 1-2 hours, collecting volatile oil, clathrating the volatile oil with sulfobutyl betacyclodextrin, and keeping the clathrate for later use; filtering the extracting solution, and concentrating to obtain clear paste with the relative density of 1.2-1.3;
preparation of aloe extract: pulverizing aloe, reflux extracting with 3 times of 75-85% ethanol for 0.2-1.0 hr, centrifuging the extractive solution, recovering ethanol under reduced pressure, and concentrating to obtain fluid extract with relative density of 1.15-1.20;
preparing pearl powder: pulverizing Margarita to obtain Margarita powder with D90 of not more than 28 μm;
(2) Preparation of the capsule contents:
mixing radix aucklandiae fluid extract, aloe fluid extract and Margarita powder, drying under reduced pressure, pulverizing into fine powder, adding clathrate and corn starch, and stirring;
(3) Preparation of aloe pearl capsules: and (3) subpackaging the content of the capsule prepared in the step (2) to obtain the aloe pearl capsule.
7. The method according to claim 6, wherein the weight of lecithin is 0.01 to 0.1 times the weight of banksia rose; preferably 0.06 times.
8. The method according to claim 6, wherein the alkaline protease is 0.02 to 0.06 times by weight of the costustoot; preferably 0.04 times.
9. The method of claim 6, wherein the flavourzyme is 0.08-0.15 times the weight of banksia rose; preferably 0.12 times.
CN202210515270.0A 2022-05-11 2022-05-11 Aloe pearl capsule and preparation method thereof Pending CN116211949A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210515270.0A CN116211949A (en) 2022-05-11 2022-05-11 Aloe pearl capsule and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210515270.0A CN116211949A (en) 2022-05-11 2022-05-11 Aloe pearl capsule and preparation method thereof

Publications (1)

Publication Number Publication Date
CN116211949A true CN116211949A (en) 2023-06-06

Family

ID=86573642

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210515270.0A Pending CN116211949A (en) 2022-05-11 2022-05-11 Aloe pearl capsule and preparation method thereof

Country Status (1)

Country Link
CN (1) CN116211949A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116763872A (en) * 2023-07-20 2023-09-19 河北君临药业有限公司 Aloe pearl capsule and preparation method thereof
CN117338869A (en) * 2023-11-22 2024-01-05 河北医科大学 A Chinese medicinal capsule and its preparation method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679746A (en) * 2005-02-05 2005-10-12 河北君临药业有限公司 Medicine for treating constipation
CN108902957A (en) * 2018-07-19 2018-11-30 深圳市博奥生物科技有限公司 A kind of capsule for relieving constipation and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679746A (en) * 2005-02-05 2005-10-12 河北君临药业有限公司 Medicine for treating constipation
CN108902957A (en) * 2018-07-19 2018-11-30 深圳市博奥生物科技有限公司 A kind of capsule for relieving constipation and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
王连国，等: "正交优选β-环糊精包合芦荟珍珠胶囊中木香挥发油的实验研究", 中国医药导报, vol. 08, no. 13, pages 62 - 63 *
申武: "莫沙必利联合培菲康及复方芦荟珍珠胶囊治疗便秘型肠易激综合征疗效观察", 实用中西医结合临床, vol. 14, no. 04, pages 79 - 80 *
许荔新，等: "芦荟珍珠胶囊的药理作用研究", 中草药, vol. 37, no. 12, pages 1854 - 1855 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116763872A (en) * 2023-07-20 2023-09-19 河北君临药业有限公司 Aloe pearl capsule and preparation method thereof
CN117338869A (en) * 2023-11-22 2024-01-05 河北医科大学 A Chinese medicinal capsule and its preparation method

Similar Documents

Publication Publication Date Title
CN116211949A (en) Aloe pearl capsule and preparation method thereof
CN101002857B (en) Traditional Chinese medicine composition, and its use
WO2005074952A1 (en) Chinese medicine for treatment of irritable bowel sysndrome and the preparation thereof
WO2020187017A1 (en) Traditional chinese medicine composition for relaxing bowels to relieve constipation, preparation method therefor and application thereof
CN101757288B (en) One treats gastrointestinal disease Chinese medicine composition and preparation method thereof
CN107126490A (en) A kind of Chinese medicine composition for preventing and treating gastrointestinal dysfunction and preparation method thereof
JP7157253B2 (en) Chinese herbal composition for enema constipation, its preparation method and its use
CN102430009B (en) Traditional Chinese medicinal composition for treating gastrointestinal disease and preparation method thereof
CN104225016B (en) A kind of pharmaceutical composition treating due to weakness of spleen and stomach chronic atrophic gastritis
CN110141619B (en) Chinese herbal medicine composition for treating constipation and preparation method of gel patch thereof
CN103212030B (en) Traditional Chinese medicine for treating liver depression type hyperplasia of mammary glands and preparation method thereof
CN111249381A (en) Application of composition in preparation of medicine for preventing and treating constipation
WO2020187018A1 (en) Traditional chinese medicine composition for loosening bowels to relieve constipation, preparation method therefor and use thereof
CN108143875B (en) Traditional Chinese medicine composition for treating diabetic gastroparesis and preparation method thereof
CN101757348B (en) Traditional Chinese medicine composition for treating gastrointestinal disease and preparation method thereof
CN113440557B (en) Traditional Chinese medicine composition for treating constipation and preparation method thereof
CN111375026B (en) Traditional Chinese medicine composition for preventing or treating obesity caused by olanzapine and preparation method, pharmaceutical preparation and application thereof
CN108704036A (en) A kind of Chinese traditional compound medicine and preparation method thereof for treating gout
CN101757529B (en) Gastrointestinal disease-treating traditional Chinese medicine composition containing fructus amomi and preparation method thereof
CN101757282B (en) Traditional Chinese medicine cataplasma for treating gastrointestinal diseases and preparation method thereof
CN117338869A (en) A Chinese medicinal capsule and its preparation method
KR102471879B1 (en) Chinese medicine for treating children constipation
CN113170848A (en) Accurate medicated diet food therapy product for preventing and treating senile functional constipation and preparation method thereof
CN101190266A (en) Chinese peony and glycyrrhiza uralensis extract and its application in preparing medicine for treating irritable bowel syndrome
WO2012006865A1 (en) Use of xanthoceras sorbifolia and xanthoceras sorbifolia extract in preparing medicaments for curing urinary incontinence or overactive bladder

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination